Abstract
A number of commercially available metal/metal oxide nanoparticles (NPs) such as superparamagnetic iron oxide (SPION) are utilized by the medical field for a wide variety of applications. These NPs may able to induce dermal toxicity via their physical nature and reactive surface properties. We hypothesize that SPION may be toxic to skin via the ability of particles to be internalized and thereby initiate oxidative stress, inducing redox-sensitive transcription factors affecting/leading to inflammation. Due to the skin’s susceptibility to UV radiation, it is also of importance to address the combined effect of UVB and NPs co-exposure. To test this hypothesis, the effects of dextran-coated SPION of different sizes (15–50 nm) and manufacturers (MicroMod, Rostock-Warnemunde, Germany and KTH-Royal Institute of Technology, Stockholm, Sweden) were evaluated in two cell lines: normal human epidermal keratinocytes (HEK) and murine epidermal cells (JB6 P+). HEK cells exposed to 20 nm (KTH and MicroMod) had a decrease in viability, while the 15 and 50 nm particles were not cytotoxic. HEK cells were also capable of internalizing the KTH particles (15 and 20 nm) but not the MicroMod SPION (20 and 50 nm). IL-8 and IL-6 were also elevated in HEK cells following exposure to SPION. Exposure of JB6 P+ cells to all SPIONs evaluated resulted in activation of AP-1. Exposure to SPION alone was not sufficient to induce NF-κB activation; however, co-exposure with UVB resulted in significant NF-κB induction in cells exposed to 15 and 20 nm KTH SPION and 50 nm MicroMod particles. Pre-exposure of JB6 P+ cells to UVB followed by NPs induced a significant depletion of glutathione, release of cytokines, and cell damage as assessed by release of lactate dehydrogenase. Altogether, these data indicate that co-exposure to UVB and SPIONs was associated with induction of oxidative stress and release of inflammatory mediators. These results verify the need to thoroughly evaluate the adverse effects of UVB when evaluating dermal toxicity of engineered NPs on skin.
Similar content being viewed by others
References
Roco, M. C., Williams, S., & Alivisatos, P. (2000). Nanotechnology research directions: IWGN workshop report. Dordrecht: Kluwer.
Muller, K., Skepper, J. N., Posfai, M., Trivedi, R., Howarth, S., Corot, C., et al. (2008). Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro. Biomaterials, 28, 1629–1642.
Weissleder, R., Bogdanov, A., Neuwelt, E. A., & Papisov, M. (1995). Long-circulating iron oxides for MR imaging. Advanced Drug Delivery Reviews, 16, 321–324.
Reimer, P., & Weissleder, R. (1996). Development and experimental application of receptor-specific MR contrast media. Radiology, 36, 153–163.
Chouly, C., Pouliquen, D., Lucet, I., Jeune, J. J., & Jallet, P. (1996). Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge, and surface nature on biodistribution. Journal of Microencapsulation, 13, 245–255.
Jung, C. W., & Jacobs, P. (1995). Physical and chemical properties of superparamagnetic iron-oxide MR contrast agents-ferumoxides, ferumoxtran, ferumoxsil. Magnetic Resonance Imaging, 13, 661–674.
Corot, C., Robert, P., Idee, J. M., & Port, M. (2006). Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced Drug Delivery Reviews, 58, 1471–1504.
Curtis, A. S. G., & Wilkinson, C. (2001). Nanotechniques and approaches in biotechnology. Trends in Biotechnology, 19, 97–101.
Moghimi, S. M., Humter, A. C. H., & Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacological Reviews, 53, 283–318.
Chan, D. C. F., Kirpotin, D., & Bunn, P. A. (1993). Synthesis and evaluation of colloidal magnetic iron-oxides for the site-specific radiofrequency-induced hyperthermia of cancer. Journal of Magnetism and Magnetic Materials, 122, 374–378.
Mornet, S., Vasseur, S., Grasset, F., & Duguet, E. (2004). Magnetic nanoparticle design for medical diagnosis and therapy. Journal of Materials Chemistry, 14, 2161–2175.
Morawski, A. M., Lanza, G. A., & Wickline, S. A. (2005). Targeted contrast agents for magnetic resonance imaging and ultrasound. Current Opinion in Biotechnology, 16(1), 89–92.
Ziv-Polat, O., Topaz, M., Brosh, T., & Margel, S. (2010). Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials, 31, 741–747.
Veiseh, O., Gunn, J. W., Kievit, F. M., Sun, C., Fang, C., Lee, J. S. H., et al. (2009). Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small (Weinheim an der Bergstrasse, Germany), 5(2), 256–264.
Moore, A., Marecos, E., Bogdanov, A., & Weissleder, R. (2000). Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology, 214, 568–574.
Huh, Y. M., Jun, Y. W., Song, H. T., Kim, S., Choi, J. S., Lee, J. H., et al. (2005). In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. Journal of the American Chemical Society, 127(35), 12387–12391.
Zhao, M., Beauregard, D. A., Loizou, L., Davletov, B., & Brindle, K. M. (2001). Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nature Medicine, 7(11), 1241–1244.
Weissleder, R., Moore, A., Mahmood, U., Bhorade, R., Benveniste, H., Chiocca, E. A., et al. (2000). In vivo magnetic resonance imaging of transgene expression. Nature Medicine, 6(3), 351–355.
Jun, Y. W., Huh, Y. M., Choi, J. S., Lee, J. H., Song, H. T., Kim, S., et al. (2005). Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. Journal of the American Chemical Society, 127(16), 5732–5733.
Bulte, J. W., Douglas, T., Witwer, B., Zhang, S. C., Strable, E., Lewis, B. K., et al. (2001). Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nature Biotechnology, 19(12), 1141–1147.
Van Beers, B. E., Pringot, J., & Gallez, B. (1995). Iron oxides as contrast agents for MRI of the liver. Journal de Radiologie, 76(11), 991–995.
Weissleder, R., Stark, D. D., Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D. L., et al. (1989). Superparamagnetic iron oxide: Pharmacokinetics and toxicity. American Journal of Radiology, 152(1), 167–173.
Weissleder, R., Elizondo, G., Wittenberg, J., Rabito, C. A., Bengele, H. H., & Josephson, L. (1990). Ultrasmall superparamagnetic iron oxide: Characterization of a new class of contrast agents for MR imaging. Radiology, 175, 489–493.
Wilhelm, C., Billotey, C., Roger, J., Pons, J. N., Bacri, J. C., & Gazeau, F. (2003). Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials, 24, 1001–1011.
Metz, S., Bonaterra, G., Rudelius, M., Settles, M., Rummeny, E. J., & Daldrup-Link, H. E. (2004). Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. European Radiology, 14, 1851–1858.
Berry, C. C., Wells, S., Charles, S., Aitchison, G., & Curtis, A. S. G. (2004). Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. Biomaterials, 25, 5405–5413.
Berry, C. C., Wells, S., Charles, S., & Curtis, A. S. G. (2003). Dextran and albumin derivatised iron oxide nanoparticles: Influence on fibroblasts in vitro. Biomaterials, 24, 4551–4557.
Martin, A. L., Bernas, L. M., Rutt, B. K., Foster, P. J., & Gillies, E. R. (2008). Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. Bioconjugate Chemistry, 19, 2375–2384.
Miyachi, Y., & Imamura, S. (1990). Photo-oxidative skin damage and antioxidants. Photodermatology Photoimmunology & Photomedicine, 7, 49–50.
Jurkiewicz, B. A., & Buettner, G. R. (1994). Ultraviolet light-induced free radical formation in skin: An electron paramagnetic resonance study. Photochemistry and Photobiology, 59, 1–4.
Trouba, K. J., Hamadeh, H. K., Amin, R. P., & Germolec, D. R. (2002). Oxidative stress and its role in skin disease. Antioxidants & Redox Signaling, 4(4), 665–673.
Alder, V., Yin, Z., Tew, K. D., & Ronai, Z. (1999). Role of redox potential and reactive oxygen species in stress signaling. Oncogene, 18, 6104–6111.
Jordan, A., Wust, P., Scholz, R., Tesche, B., Fahling, H., Mitrovics, T., et al. (1996). Cellular uptake of magnetic fluid particles and their effects on human carcinoma cells exposed to AC magnetic fields in vitro. International Journal of Hyperthermia, 12(6), 705–722.
Dhar, A., Young, M. R., & Colburn, N. H. (2002). The role of AP-1, NF-kB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive. Molecular and Cellular Biochemistry, 234(235), 185–193.
Colburn, N. H., Former, B. F., Nelson, K. A., & Yuspa, S. H. (1979). Tumour promoter induces anchorage independent irreversibility. Nature, 281, 589–591.
Colburn, N. H., & Lockyer, J. (1982). Phobol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells. Cancer Research, 42, 3093–3097.
Keane, R. W., Srinivasan, A., Foster, L. M., Testa, M. P., Ord, T., Nonner, D., et al. (1997). Activation of CPP32 during apoptosis of neurons and astrocytes. Journal of Neuroscience Research, 48, 168–180.
Monteiro-Riviere, N. A., Inman, A. O., & Zhang, L. W. (2009). Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in human cell line. Toxicology and Applied Pharmacology, 234, 222–235.
Shvedova, A. A., Kommineni, C., Jeffries, B. A., Castranova, V., Tyurina, Y. Y., Tyurin, V. A., et al. (2000). Redox cycling of phenol induces oxidative stress in human epidermal keratinocytes. Journal of Investigative Dermatology, 114, 354–364.
Driscoll, K. E., Carter, J. M., Hassenbein, D. G., & Howard, B. (1997). Cytokines and particle-induced inflammatory cell recruitment. Environmental Health Perspectives, 105(Suppl 5), 1159–1164.
Mossman, B. T., & Churg, A. (1998). Mechanisms in the pathogenesis of asbestosis and silicosis. American Journal of Respiratory and Critical Care Medicine, 157, 1666–1680.
Schins, R. P., & Borm, P. J. (1999). Mechanisms and mediators in coal dust induced toxicity: A review. Annals of Occupational Hygiene, 43, 7–33.
Siglienti, I., Bendszus, M., Kleinschnitz, C., & Stoll, G. (2006). Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging. Journal of Neuroimmunology, 173, 166–173.
Gupta, A. K., & Curtis, A. S. G. (2004). Surface modified superparamagnetic nanoparticles for drug delivery: Interaction studies with human fibroblasts in culture. Journal of Materials Science, 15, 493–496.
Moore, A., Weissleder, R., & Bogdanov, A. (1997). Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. Journal of Magnetic Resonance Imaging, 7, 1140–1145.
Schulze, E., Ferrucci, J. T., Poss, K., Lapointe, L., Bogdanova, A., & Weissleder, R. (1995). Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Investigative Radiology, 30, 604–610.
Fuchs, J., & Kern, H. (1998). Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: A clinical study using solar simulated radiation. Free Radical Biology & Medicine, 25, 1006–1012.
Kligman, L. H., & Kligman, A. M. (1986). The nature of photoaging: Its prevention and repair. Photodermatology, 3, 215–227.
Longstreth, J., de Gruijl, F. R., Kripke, M. L., Abseck, S., Arnold, F., Slaper, H. I., et al. (1998). Health risks. Journal of Photochemistry and Photobiology B: Biology, 46, 20–39.
Black, H. S. (1987). Potential involvement of free radical reactions in ultraviolet light- mediated cutaneous damage. Photochemistry and Photobiology, 46, 213–221.
Darr, D., & Fridovich, I. (1994). Free radicals in cutaneous biology. Journal of Investigative Dermatology, 102, 671–675.
Kvam, E., & Dhale, J. (2003). Pigmented melanocytes are protected against ultraviolet-A-induced membrane damage. Journal of Investigative Dermatology, 121, 564–569.
Carbonare, M. D., & Pathak, M. A. (1992). Skin photosensitizing agents and the role of reactive oxygen species in photoaging. Journal of Photochemistry and Photobiology B: Biology, 14, 105–124.
Babincova, M., Leszczynska, D., Sourivong, P., & Babinec, P. (2000). Selective treatment of neoplastic cells using ferritin-mediated electromagnetic hyperthermia. Medical Hypotheses, 54(3), 177–179.
Schafer, F. Q., & Buettner, G. R. (2001). Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radical Biology & Medicine, 30, 1191–1212.
Sies, H. (1999). Glutathione and its role in cellular function. Free Radical Biology & Medicine, 27, 916–921.
Kohen, R., & Nyska, A. (2003). Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology, 30(6), 620–650.
Haddad, J. J. (2000). Glutathione depletion is associated with augmenting a proinflammatory signal: Evidence for an antioxidant/pro-oxidant mechanism regulating cytokines in the alveolar epithelium. Cytokines, Cellular & Molecular Therapy, 6, 177–187.
Haddad, J. J. (2002). Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: Role for nuclear factor-kappa B. Critical Care, 6(6), 481–490.
Haddad, J. J. (2002). Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cellular Signalling, 14(11), 879–897.
Hudson, V. M. (2001). Rethinking cystic fibrosis pathology: The critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radical Biology & Medicine, 30, 1440–1461.
Petroff, M. G., Petroff, B. K., & Pate, J. L. (2001). Mechanisms of cytokine-induced death of cultured bovine luteal cells. Reproduction, 121, 753–760.
Gosset, P., Wallaert, B., Tonnel, A. B., & Fourneau, C. (1999). Thiol regulation of the production of TNF-α, IL-6, and IL-8 by human alveolar macrophages. European Respiratory Journal, 14, 98–105.
Lopez-Torres, M., Thiele, J. J., Shindo, Y., Han, D., & Packer, L. (1998). Topical application of a-tocopherol modulates the antioxidant network and diminishes ultraviolet-induced oxidative damage in murine skin. British Journal of Dermatology, 138, 207–215.
Halliwell, B., & Cross, C. E. (1994). Oxygen-derived species: Their relation to human disease and environmental stress. Environmental Health Perspectives, 102, 5–12.
Nackbar, F., & Korting, H. C. (1995). The role of vitamin E in normal and damaged skin. Journal of Molecular Medicine, 73, 7–17.
Meyer, M., Pahl, H. L., & Bauerle, P. A. (1994). Regulation of the transcription factor NF-kB and AP-1 by redox changes. Chemico-Biological Interacttions, 91, 91–100.
Abate, C., & Curran, T. (1990). Encounters with Fos and Jun on the road to AP-1. Seminars in Cancer Biology, 1, 19–26.
Toledano, M. B., & Leonard, W. J. (1991). Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proceedings of the National Academy of Sciences of the United States of America, 88, 4328–4332.
Boyle, W. J., Smeal, T., Defize, L. H., Angel, P., Woodgett, J. R., Karin, M., et al. (1991). Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell, 64(3), 73–84.
Papavassiliou, A. G., Bohmann, K., & Bohmann, D. (1992). Determining the effect of inducible protein phosphorylation on the DNA-binding activity of transcription factors. Analytical Biochemistry, 203(2), 302–309.
Cerruti, P. A. (1989). Response modification in carcinogenesis. Environmental Health Perspectives, 81, 39–43.
Schreck, R., Reiber, P., & Baeuerle, P. A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa-B transcription factor and HIV-1. EMBO Journal, 10(8), 2247–2258.
Schreck, R., & Baeuerle, P. A. (1991). A role for oxygen radicals as second messengers. Trends in Cell Biology, 1(2–3), 39–42.
Barker, J., Mitra, R., Griffiths, C., Dixit, V., & Nickoloff, B. (1991). Keratinocytes as initiators of inflammation. Lancet, 337, 211–214.
Corsini, E., & Galli, C. (1998). Cytokines and contact dermatitis. Toxicology Letters, 102–103, 277–282.
Grone, A. (2002). Keratinocytes and cytokines. Veterinary Immunology and Immunopathology, 88, 1–12.
Nickolof, B. (1991). The cytokine network in psoriasis. Archives of Dermatological Research, 127, 871–884.
Chabot-Fletcher, M., Breton, J., Lee, J., Young, P., & Griswold, D. (1994). Interleukin-8 production is regulated by protein kinase C in human keratinocytes. Journal of Investigative Dermatology, 103, 509–515.
Hsaio, J. K., Chu, H. H., Wang, Y. H., Lai, C. W., Chou, P. T., Hsieh, S. T., et al. (2008). Macrophage physiological function after superparamagnetic iron oxide labeling. NMR in Biomedicine, 21, 820–829.
Acknowledgments
This work was supported by NIOSH OH008282, NORA 927Z1LU and the 7th Framework Program of the European Commission (EC-FP-7-NANOMMUNE-214281).
Disclaimer
The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the National Institute for Occupational Safety and Health.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murray, A.R., Kisin, E., Inman, A. et al. Oxidative Stress and Dermal Toxicity of Iron Oxide Nanoparticles In Vitro. Cell Biochem Biophys 67, 461–476 (2013). https://doi.org/10.1007/s12013-012-9367-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-012-9367-9